Quarter Financials
Karyopharm Therapeutics Inc. (KPTI)
$0.7908
+0.02 (+2.70%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q3
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
|---|
| Net Income | -35 | -33 | -34 | -39 | -36 | -49 | -41 | 39 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -1,445 | -1,411 | -1,378 | -1,344 | -1,305 | -1,269 | -1,220 | -1,179 |
|---|
|
Year
|
2023 Q3
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
|---|
| Capital Expenditure | - | - | - | 0 | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 5 | 6 | 7 | 7 | 8 | 9 | 9 | 2 |
|---|
|
Year
|
2023 Q3
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
|---|
| New Purchases | - | -36 | -63 | -30 | -97 | -60 | -36 | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|